Kappa Opioid Receptor Imaging in Anorexia
NCT02240797 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2016-08-17
Summary
The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.
Conditions
- Anorexia Nervosa
Interventions
- OTHER
-
Positron emission tomography (PET) imaging
Positron emission tomography (PET) imaging
Sponsors & Collaborators
-
Yale University
collaborator OTHER -
Icahn School of Medicine at Mount Sinai
collaborator OTHER - lead OTHER
Principal Investigators
-
Charles Marmar, MD · NYU School of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- United States
Study Locations
More Related Trials
-
FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD
NCT04311281 ·Status: WITHDRAWN
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children
NCT00392730 ·Status: COMPLETED
-
PET Scan of Brain Metabolism in Relation to Age and Disease
NCT00001972 ·Status: COMPLETED
-
PET Tau - Neurodegenerative Disease Imaging
NCT03143374 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Brain Sleep Deprivation MRI Effects (BEDTIME)
NCT02741505 ·Status: WITHDRAWN ·Phase: NA
-
Imaging Glutamate Release From Alcohol
NCT04159688 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
AI-powered Portable MRI Abnormality Detection
NCT06803420 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
68Ga-NY104 PET/CT in Von Hippel-Lindau Disease
NCT05810246 ·Status: RECRUITING ·Phase: PHASE2
-
Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid
NCT02343757 ·Status: TERMINATED ·Phase: NA
-
A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease
NCT01122329 ·Status: COMPLETED ·Phase: PHASE4
-
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3
-
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
NCT00966017 ·Status: UNKNOWN
-
Prolonged Gadolinium Retention After MRI Imaging
NCT02421029 ·Status: WITHDRAWN ·Phase: PHASE4
-
Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System
NCT00424957 ·Status: COMPLETED
-
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand
NCT03958630 ·Status: TERMINATED ·Phase: PHASE1
-
Positron Emission Tomography (PET) to Study Brain Signaling
NCT00044200 ·Status: COMPLETED
-
Brain Manganese Deposition in High Risk Neonates
NCT00392977 ·Status: COMPLETED
-
PET/MRI Imaging of Glutamate Release in the Brain
NCT02511691 ·Status: TERMINATED ·Phase: PHASE2
-
Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury
NCT01044615 ·Status: COMPLETED
-
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
NCT04643015 ·Status: ACTIVE_NOT_RECRUITING
-
Food Reward in Cachexia Induced by Acute or Chronic Disease
NCT02798003 ·Status: TERMINATED
-
Normal Binding of R-[11C]PK11195 in Human Subjects
NCT00205595 ·Status: UNKNOWN ·Phase: PHASE1
-
A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants
NCT05320302 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome
NCT02743377 ·Status: COMPLETED ·Phase: PHASE1/PHASE2